StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

HCABullishAnalyst Target Updateanalyst
Medium materiality4/10

KeyBanc raises HCA Healthcare price target to $490 from $435

Oct 28, 2026, 11:22 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

The material target increase is bullish, though the limited gap between the target and posted price tempers the signal.

AI summary

What happened, with direct paths to the underlying reporting

KeyBanc raised its HCA target by about 13% to $490, roughly 6% above the posted price of $462.29. The stock was down 0.02% since the signal.

  • Target raised from $435 to $490.
  • Posted price: $462.29; price change since signal: -0.02%.

Key facts

  1. 01

    Target: $490

  2. 02

    Posted price: $462.29

  3. 03

    Analyst firm: KeyBanc

  4. 04

    Analyst: Matthew Gillmor

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.